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Introduction
We previously reported that low doses of the purified
stabilized bovine haemoglobin (EXP1) improved survival
in a severe haemorrhage reperfusion model with benefi-
cial effects on oxidative stress (unpublished data). We
here report additional findings on a similar formulation,
EXP2, at different doses using the same model of shock
resuscitation.
Methods
Male Wistar rats (weight 306 ± 15g) underwent arterial
and central venous cannulation, tracheostomy, bladder
catheterization and placement of a liver tissue pO2 sen-
sor (Oxford Optronix, Oxford, UK). Controlled haemor-
rhage (45% of estimated blood volume) was induced
over 15 minutes and sustained shock (MAP target 40-45
mmHg) was maintained for an additional 75 minutes.
After crystalloid resuscitation, animals were randomized
to receive a bolus injection of either Ringer’s lactate
(control) or EXP2 at 200, 400 or 900 mg/kg (New A
Innovation Limited, Hong Kong). 700 mg/kg is approxi-
mately equivalent to a one-unit blood transfusion. Con-
tinuous i.v. fluid administration (10 mg/kg/hr) was then
infused for the following 4 hours. Echocardiography,
blood gas analysis, blood pressure and liver tissue pO2
were measured pre- and post- insult, and then at hourly
intervals. Two-way ANOVA with post-hoc t testing was
used to detect statistically significant differences.
Results
Four-hour survival was 50%, 87.5%, 66.7% and 62.5% for
the control, 200, 400 and 900 mg/kg groups, respectively. Small but significant changes were seen in plasma Hb
levels, no changes were seen in lactate or oxygen delivery,
while liver tissue pO2 increased only in the 400 mg/kg
group. Notably, urine output improved at all EXP2 doses,
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particularly in the 900 mg/kg group, though the pressor
effect was identical for all doses of EXP2.
Conclusions
Low dose stabilized haemoglobin solution has potential
utility in the treatment of global ischaemia-reperfusion
injury though further work is needed to clarify optimal
dose and mechanism(s) of action.
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